A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin

Youn Ho Kim; Woo Sik Han; Sun Jae Lee; Sung Nam Oh; Do Won Choi; Kwan Soo Byun; Jong Eun Yeon

doi:10.3350/kjhep.2007.13.3.419

A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin

Youn Ho Kim, Woo Sik Han, Sun Jae Lee, Sung Nam Oh, Do Won Choi, Kwan Soo Byun, Jong Eun Yeon

Research output: Contribution to journal › Article › peer-review

Abstract

There has been an increase in the number of patients treated with pegylated interferon (PEG-IFN) and ribavirin due to the better antiviral efficacy. The main serious adverse events of PEG-IFN plus ribavirin combination therapy are bone marrow suppression and hemolytic anemia. However, there are few reports of vasculitis occurring during PEG-IFN therapy. We describe a patient who developed vasculitis during the treatment of chronic hepatitis C with PEG-IFN and ribavirin.

Original language	English
Pages (from-to)	419-422
Number of pages	4
Journal	The Korean journal of hepatology
Volume	13
Issue number	3
DOIs	https://doi.org/10.3350/kjhep.2007.13.3.419
Publication status	Published - 2007
Externally published	Yes

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3350/kjhep.2007.13.3.419

Cite this

@article{4effec448af74326ac7a7de001a90c9d,

title = "A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin",

abstract = "There has been an increase in the number of patients treated with pegylated interferon (PEG-IFN) and ribavirin due to the better antiviral efficacy. The main serious adverse events of PEG-IFN plus ribavirin combination therapy are bone marrow suppression and hemolytic anemia. However, there are few reports of vasculitis occurring during PEG-IFN therapy. We describe a patient who developed vasculitis during the treatment of chronic hepatitis C with PEG-IFN and ribavirin.",

author = "Kim, {Youn Ho} and Han, {Woo Sik} and Lee, {Sun Jae} and Oh, {Sung Nam} and Choi, {Do Won} and Byun, {Kwan Soo} and Yeon, {Jong Eun}",

year = "2007",

doi = "10.3350/kjhep.2007.13.3.419",

language = "English",

volume = "13",

pages = "419--422",

journal = "The Korean journal of hepatology",

issn = "1738-222X",

publisher = "Korean Association for the Study of the Liver",

number = "3",

}

TY - JOUR

T1 - A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin

AU - Kim, Youn Ho

AU - Han, Woo Sik

AU - Lee, Sun Jae

AU - Oh, Sung Nam

AU - Choi, Do Won

AU - Byun, Kwan Soo

AU - Yeon, Jong Eun

PY - 2007

Y1 - 2007

N2 - There has been an increase in the number of patients treated with pegylated interferon (PEG-IFN) and ribavirin due to the better antiviral efficacy. The main serious adverse events of PEG-IFN plus ribavirin combination therapy are bone marrow suppression and hemolytic anemia. However, there are few reports of vasculitis occurring during PEG-IFN therapy. We describe a patient who developed vasculitis during the treatment of chronic hepatitis C with PEG-IFN and ribavirin.

AB - There has been an increase in the number of patients treated with pegylated interferon (PEG-IFN) and ribavirin due to the better antiviral efficacy. The main serious adverse events of PEG-IFN plus ribavirin combination therapy are bone marrow suppression and hemolytic anemia. However, there are few reports of vasculitis occurring during PEG-IFN therapy. We describe a patient who developed vasculitis during the treatment of chronic hepatitis C with PEG-IFN and ribavirin.

UR - http://www.scopus.com/inward/record.url?scp=58149087841&partnerID=8YFLogxK

U2 - 10.3350/kjhep.2007.13.3.419

DO - 10.3350/kjhep.2007.13.3.419

M3 - Article

C2 - 17898559

AN - SCOPUS:58149087841

SN - 1738-222X

VL - 13

SP - 419

EP - 422

JO - The Korean journal of hepatology

JF - The Korean journal of hepatology

IS - 3

ER -

A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this